康臣药业-20240821

Summary of the Conference Call Company and Industry - The conference call pertains to Kongcheng Pharmaceutical, focusing on its 2024 mid-year performance report Core Points and Arguments - The call began with a welcome message and a statement regarding the confidentiality of the content, indicating that it is intended solely for Xinyi Securities clients [1] Other Important but Possibly Overlooked Content - The audio and text records of the meeting are copyrighted by Xinyi Securities, and any reproduction without permission is considered an infringement [1]